Literature DB >> 23300083

Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice.

Meghan E McGee-Lawrence1, Xiaodong Li, Krista L Bledsoe, Hai Wu, John R Hawse, Malayannan Subramaniam, David F Razidlo, Bridget A Stensgard, Gary S Stein, Andre J van Wijnen, Jane B Lian, Wei Hsu, Jennifer J Westendorf.   

Abstract

Runx2 and Axin2 regulate craniofacial development and skeletal maintenance. Runx2 is essential for calvarial bone development, as Runx2 haploinsufficiency causes cleidocranial dysplasia. In contrast, Axin2-deficient mice develop craniosynostosis because of high β-catenin activity. Axin2 levels are elevated in Runx2(-/-) calvarial cells, and Runx2 represses transcription of Axin2 mRNA, suggesting a direct relationship between these factors in vivo. Here we demonstrate that Runx2 binds several regions of the Axin2 promoter and that Runx2-mediated repression of Axin2 transcription depends on Hdac3. To determine whether Runx2 contributes to the etiology of Axin2 deficiency-induced craniosynostosis, we generated Axin2(-/-):Runx2(+/-) mice. These double mutant mice had longer skulls than Axin2(-/-) mice, indicating that Runx2 haploinsufficiency rescued the craniosynostosis phenotype of Axin2(-/-) mice. Together, these studies identify a key mechanistic pathway for regulating intramembranous bone development within the skull that involves Runx2- and Hdac3-mediated suppression of Axin2 to prevent the untimely closure of the calvarial sutures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23300083      PMCID: PMC3581413          DOI: 10.1074/jbc.M112.414995

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development.

Authors:  Takamitsu Maruyama; Anthony J Mirando; Chu-Xia Deng; Wei Hsu
Journal:  Sci Signal       Date:  2010-05-25       Impact factor: 8.192

2.  Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis.

Authors:  Andrew O M Wilkie; Jo C Byren; Jane A Hurst; Jayaratnam Jayamohan; David Johnson; Samantha J L Knight; Tracy Lester; Peter G Richards; Stephen R F Twigg; Steven A Wall
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

3.  Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Authors:  Eek-hoon Jho; Tong Zhang; Claire Domon; Choun-Ki Joo; Jean-Noel Freund; Frank Costantini
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  Early onset of Runx2 expression caused craniosynostosis, ectopic bone formation, and limb defects.

Authors:  Takafumi Maeno; Takeshi Moriishi; Carolina Andrea Yoshida; Hisato Komori; Naoko Kanatani; Shin-ichi Izumi; Kunio Takaoka; Toshihisa Komori
Journal:  Bone       Date:  2011-07-23       Impact factor: 4.398

5.  AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.

Authors:  S Meyers; N Lenny; W Sun; S W Hiebert
Journal:  Oncogene       Date:  1996-07-18       Impact factor: 9.867

6.  Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth.

Authors:  Neus Martínez-Abadías; Christopher Percival; Kristina Aldridge; Cheryl A Hill; Timothy Ryan; Satama Sirivunnabood; Yingli Wang; Ethylin Wang Jabs; Joan T Richtsmeier
Journal:  Dev Dyn       Date:  2010-11       Impact factor: 3.780

7.  Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation.

Authors:  Tania M Schroeder; Rachel A Kahler; Xiaodong Li; Jennifer J Westendorf
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157

8.  Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat.

Authors:  David F Razidlo; Tiffany J Whitney; Michelle E Casper; Meghan E McGee-Lawrence; Bridget A Stensgard; Xiaodong Li; Frank J Secreto; Sarah K Knutson; Scott W Hiebert; Jennifer J Westendorf
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

9.  β-catenin/cyclin D1 mediated development of suture mesenchyme in calvarial morphogenesis.

Authors:  Anthony J Mirando; Takamitsu Maruyama; Jiang Fu; Hsiao-Man Ivy Yu; Wei Hsu
Journal:  BMC Dev Biol       Date:  2010-11-26       Impact factor: 1.978

10.  Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.

Authors:  J Akech; J J Wixted; K Bedard; M van der Deen; S Hussain; T A Guise; A J van Wijnen; J L Stein; L R Languino; D C Altieri; J Pratap; E Keller; G S Stein; J B Lian
Journal:  Oncogene       Date:  2009-11-16       Impact factor: 9.867

View more
  21 in total

1.  Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.

Authors:  Héctor F Araya; Hugo Sepulveda; Carlos O Lizama; Oscar A Vega; Sofia Jerez; Pedro F Briceño; Roman Thaler; Scott M Riester; Marcelo Antonelli; Flavio Salazar-Onfray; Juan Pablo Rodríguez; Ricardo D Moreno; Martin Montecino; Martine Charbonneau; Claire M Dubois; Gary S Stein; Andre J van Wijnen; Mario A Galindo
Journal:  J Cell Biochem       Date:  2018-06-19       Impact factor: 4.429

2.  Enhanced prostacyclin formation and Wnt signaling in sclerostin deficient osteocytes and bone.

Authors:  Zachary C Ryan; Theodore A Craig; Jeffrey L Salisbury; Lomeli R Carpio; Meghan McGee-Lawrence; Jennifer J Westendorf; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2014-04-26       Impact factor: 3.575

3.  Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin sensitivity.

Authors:  Meghan E McGee-Lawrence; Jessica L Pierce; Kanglun Yu; Natasha R Culpepper; Elizabeth W Bradley; Jennifer J Westendorf
Journal:  J Cell Physiol       Date:  2017-09-12       Impact factor: 6.384

4.  Role of WNT16 in the regulation of periosteal bone formation in female mice.

Authors:  Jon E Wergedal; Chandrasekhar Kesavan; Robert Brommage; Subhashri Das; Subburaman Mohan
Journal:  Endocrinology       Date:  2014-12-18       Impact factor: 4.736

5.  Sclerostin deficient mice rapidly heal bone defects by activating β-catenin and increasing intramembranous ossification.

Authors:  Meghan E McGee-Lawrence; Zachary C Ryan; Lomeli R Carpio; Sanjeev Kakar; Jennifer J Westendorf; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2013-11-06       Impact factor: 3.575

6.  A positive role of microRNA-15b on regulation of osteoblast differentiation.

Authors:  S Vimalraj; Nicola C Partridge; N Selvamurugan
Journal:  J Cell Physiol       Date:  2014-09       Impact factor: 6.384

7.  Photobiomodulation and bone healing in diabetic rats: evaluation of bone response using a tibial defect experimental model.

Authors:  Angela Maria Paiva Magri; Kelly Rossetti Fernandes; Lívia Assis; Nathalia Antal Mendes; Ana Lúcia Yaeko da Silva Santos; Edilson de Oliveira Dantas; Ana Claudia Rennó
Journal:  Lasers Med Sci       Date:  2015-07-30       Impact factor: 3.161

8.  Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2).

Authors:  Lance A Stechschulte; Chunxi Ge; Terry D Hinds; Edwin R Sanchez; Renny T Franceschi; Beata Lecka-Czernik
Journal:  J Biol Chem       Date:  2016-09-29       Impact factor: 5.157

9.  Effects of low-level laser therapy on the expression of osteogenic genes during the initial stages of bone healing in rats: a microarray analysis.

Authors:  Carla Roberta Tim; Paulo Sérgio Bossini; Hueliton Wilian Kido; Iran Malavazi; Marcia Regina von Zeska Kress; Marcelo Falsarella Carazzolle; Nivaldo Antonio Parizotto; Ana Cláudia Rennó
Journal:  Lasers Med Sci       Date:  2015-09-28       Impact factor: 3.161

10.  Runx2 is required for early stages of endochondral bone formation but delays final stages of bone repair in Axin2-deficient mice.

Authors:  Meghan E McGee-Lawrence; Lomeli R Carpio; Elizabeth W Bradley; Amel Dudakovic; Jane B Lian; Andre J van Wijnen; Sanjeev Kakar; Wei Hsu; Jennifer J Westendorf
Journal:  Bone       Date:  2014-06-25       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.